HealthPhoto: Deccan HeraldCDSCO: No Separate Export NOC Needed for r-DNA Drugs with Brand Name Changes
The Central Drugs Standard Control Organisation (CDSCO) clarified that recombinant-DNA (r-DNA) drugs with authorized Indian marketing approval do not require a separate export no-objection certificate (NOC) if exported under different brand names, provided the drug composition remains unchanged. The CDSCO stated firms with valid marketing authorization can directly apply for export permission using Form 28-D without needing a separate export NOC.
Deccan Herald·



